• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去泛素化酶在心脏疾病中的作用。

The role of deubiquitinases in cardiac disease.

机构信息

Department of Nephrology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, People's Republic of China.

出版信息

Expert Rev Mol Med. 2024 Mar 25;26:e3. doi: 10.1017/erm.2024.2.

DOI:10.1017/erm.2024.2
PMID:38525836
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11062144/
Abstract

Deubiquitinases are a group of proteins that identify and digest monoubiquitin chains or polyubiquitin chains attached to substrate proteins, preventing the substrate protein from being degraded by the ubiquitin-proteasome system. Deubiquitinases regulate cellular autophagy, metabolism and oxidative stress by acting on different substrate proteins. Recent studies have revealed that deubiquitinases act as a critical regulator in various cardiac diseases, and control the onset and progression of cardiac disease through a board range of mechanism. This review summarizes the function of different deubiquitinases in cardiac disease, including cardiac hypertrophy, myocardial infarction and diabetes mellitus-related cardiac disease. Besides, this review briefly recapitulates the role of deubiquitinases modulators in cardiac disease, providing the potential therapeutic targets in the future.

摘要

去泛素化酶是一组能够识别和分解连接在底物蛋白上的单泛素链或多泛素链的蛋白质,防止底物蛋白被泛素蛋白酶体系统降解。去泛素化酶通过作用于不同的底物蛋白来调节细胞自噬、代谢和氧化应激。最近的研究表明,去泛素化酶在各种心脏疾病中作为关键调节剂发挥作用,并通过广泛的机制控制心脏疾病的发生和进展。本综述总结了不同去泛素化酶在心脏疾病中的作用,包括心脏肥大、心肌梗死和糖尿病相关的心脏疾病。此外,本综述简要回顾了去泛素化酶调节剂在心脏疾病中的作用,为未来提供了潜在的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9388/11062144/6fb5cec163a6/S1462399424000024_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9388/11062144/435cc4dc7620/S1462399424000024_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9388/11062144/6fb5cec163a6/S1462399424000024_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9388/11062144/435cc4dc7620/S1462399424000024_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9388/11062144/6fb5cec163a6/S1462399424000024_fig2.jpg

相似文献

1
The role of deubiquitinases in cardiac disease.去泛素化酶在心脏疾病中的作用。
Expert Rev Mol Med. 2024 Mar 25;26:e3. doi: 10.1017/erm.2024.2.
2
The emerging role of Deubiquitinases (DUBs) in parasites: A foresight review.去泛素化酶(DUBs)在寄生虫中的新兴作用:前瞻性综述。
Front Cell Infect Microbiol. 2022 Sep 27;12:985178. doi: 10.3389/fcimb.2022.985178. eCollection 2022.
3
Cracking the Monoubiquitin Code of Genetic Diseases.破解遗传疾病的单泛素化密码
Int J Mol Sci. 2020 Apr 25;21(9):3036. doi: 10.3390/ijms21093036.
4
Breaking the chains: deubiquitylating enzyme specificity begets function.打破束缚:去泛素化酶的特异性产生功能。
Nat Rev Mol Cell Biol. 2019 Jun;20(6):338-352. doi: 10.1038/s41580-019-0099-1.
5
Identification of Deubiquitinase Substrates in Saccharomyces cerevisiae by Systematic Overexpression.通过系统性过表达鉴定酿酒酵母中的去泛素化酶底物
Methods Mol Biol. 2023;2591:237-253. doi: 10.1007/978-1-0716-2803-4_14.
6
Identification and characterization of diverse OTU deubiquitinases in bacteria.鉴定和表征细菌中多样化的 OTU 去泛素化酶。
EMBO J. 2020 Aug 3;39(15):e105127. doi: 10.15252/embj.2020105127. Epub 2020 Jun 22.
7
Molecular basis of Lys11-polyubiquitin specificity in the deubiquitinase Cezanne.去泛素化酶Cezanne中Lys11-多聚泛素特异性的分子基础
Nature. 2016 Oct 20;538(7625):402-405. doi: 10.1038/nature19836. Epub 2016 Oct 12.
8
Neutron-encoded diubiquitins to profile linkage selectivity of deubiquitinating enzymes.基于中子编码的双泛素组以分析去泛素化酶的连接选择性。
Nat Commun. 2023 Mar 25;14(1):1661. doi: 10.1038/s41467-023-37363-6.
9
Disassembly of Lys11 and mixed linkage polyubiquitin conjugates provides insights into function of proteasomal deubiquitinases Rpn11 and Ubp6.赖氨酸11连接和混合连接多聚泛素缀合物的拆解为蛋白酶体去泛素化酶Rpn11和Ubp6的功能提供了见解。
J Biol Chem. 2015 Feb 20;290(8):4688-4704. doi: 10.1074/jbc.M114.568295. Epub 2014 Nov 11.
10
Proteasome inhibition during myocardial infarction.心肌梗死后蛋白酶体抑制。
Cardiovasc Res. 2010 Jan 15;85(2):312-20. doi: 10.1093/cvr/cvp309. Epub 2009 Sep 10.

引用本文的文献

1
NEDD4L-Mediated Ubiquitination of GPX4 Exacerbates Doxorubicin-Induced Cardiotoxicity.NEDD4L介导的GPX4泛素化加剧阿霉素诱导的心脏毒性。
Int J Mol Sci. 2025 Aug 23;26(17):8201. doi: 10.3390/ijms26178201.
2
Regulation of disease signaling by YOD1: potential implications for therapeutic strategies.YOD1对疾病信号的调控:对治疗策略的潜在影响。
Cancer Cell Int. 2025 Jun 24;25(1):232. doi: 10.1186/s12935-025-03881-0.
3
The roles of the ubiquitin-proteasome system in renal disease.泛素 - 蛋白酶体系统在肾脏疾病中的作用。

本文引用的文献

1
Deubiquitinase JOSD2 improves calcium handling and attenuates cardiac hypertrophy and dysfunction by stabilizing SERCA2a in cardiomyocytes.去泛素化酶 JOSD2 通过稳定心肌细胞中的 SERCA2a 改善钙处理,减轻心肌肥厚和功能障碍。
Nat Cardiovasc Res. 2023 Aug;2(8):764-777. doi: 10.1038/s44161-023-00313-y. Epub 2023 Aug 7.
2
Deubiquitinase OTUD5 as a Novel Protector against 4-HNE-Triggered Ferroptosis in Myocardial Ischemia/Reperfusion Injury.去泛素化酶 OTUD5 作为一种新型保护剂,可抵抗心肌缺血/再灌注损伤中 4-HNE 触发的铁死亡。
Adv Sci (Weinh). 2023 Oct;10(28):e2301852. doi: 10.1002/advs.202301852. Epub 2023 Aug 8.
3
Int J Med Sci. 2025 Mar 10;22(8):1791-1810. doi: 10.7150/ijms.107284. eCollection 2025.
4
Cardiomyocyte-Enriched USP20 Ameliorates Pathological Cardiac Hypertrophy by Targeting STAT3 Deubiquitination.富含心肌细胞的USP20通过靶向STAT3去泛素化改善病理性心肌肥大。
Adv Sci (Weinh). 2025 Jun;12(23):e2416478. doi: 10.1002/advs.202416478. Epub 2025 Apr 7.
5
USP5 Deletion Inhibits KD Serum Induced-Human Coronary Artery Endothelial Cell Dysfunction by Regulating the NFATC1/TLR4-Mediated NF-κB Signaling Pathway in Kawasaki Disease.USP5缺失通过调节川崎病中NFATC1/TLR4介导的NF-κB信号通路抑制川崎病血清诱导的人冠状动脉内皮细胞功能障碍。
Inflammation. 2025 Mar 7. doi: 10.1007/s10753-025-02276-7.
6
Emerging Role of Targeting Deubiquitinating Enzymes to Inhibit Pathological Cardiac Hypertrophy.靶向去泛素化酶抑制病理性心肌肥大的新作用
J Am Heart Assoc. 2025 Mar 18;14(6):e039732. doi: 10.1161/JAHA.124.039732. Epub 2025 Mar 5.
7
Pathological roles of ubiquitination and deubiquitination systems in sepsis-induced myocardial dysfunction.泛素化和去泛素化系统在脓毒症诱导的心肌功能障碍中的病理作用。
Biomol Biomed. 2025 May 8;25(7):1444-1458. doi: 10.17305/bb.2024.11738.
8
Deubiquitinases as novel therapeutic targets for diseases.去泛素化酶作为疾病的新型治疗靶点。
MedComm (2020). 2024 Dec 13;5(12):e70036. doi: 10.1002/mco2.70036. eCollection 2024 Dec.
Loss of USP22 alleviates cardiac hypertrophy induced by pressure overload through HiF1-α-TAK1 signaling pathway.
USP22 的缺失通过 HiF1-α-TAK1 信号通路减轻了压力超负荷引起的心脏肥大。
Biochim Biophys Acta Mol Basis Dis. 2023 Dec;1869(8):166813. doi: 10.1016/j.bbadis.2023.166813. Epub 2023 Jul 23.
4
Upregulation of glycolytic enzyme PFKFB3 by deubiquitinase OTUD4 promotes cardiac fibrosis post myocardial infarction.去泛素化酶 OTUD4 通过上调糖酵解酶 PFKFB3 促进心肌梗死后的心脏纤维化。
J Mol Med (Berl). 2023 Jun;101(6):743-756. doi: 10.1007/s00109-023-02323-6. Epub 2023 May 10.
5
OTUD1 promotes pathological cardiac remodeling and heart failure by targeting STAT3 in cardiomyocytes.OTUD1 通过靶向心肌细胞中的 STAT3 促进病理性心脏重构和心力衰竭。
Theranostics. 2023 Apr 17;13(7):2263-2280. doi: 10.7150/thno.83340. eCollection 2023.
6
Ubiquitin-specific protease 11 Aggravates Ischemia-reperfusion-induced Cardiomyocyte Pyroptosis and Injury by Promoting TRAF3 Deubiquitination.泛素特异性蛋白酶 11 通过促进 TRAF3 去泛素化加重缺血再灌注诱导的心肌细胞焦亡和损伤。
Balkan Med J. 2023 May 8;40(3):205-214. doi: 10.4274/balkanmedj.galenos.2023.2022-12-15. Epub 2023 Mar 31.
7
Experimental and Clinical Aspects of Sevoflurane Preconditioning and Postconditioning to Alleviate Hepatic Ischemia-Reperfusion Injury: A Scoping Review.七氟醚预处理和后处理减轻肝缺血再灌注损伤的实验和临床研究:范围综述。
Int J Mol Sci. 2023 Jan 25;24(3):2340. doi: 10.3390/ijms24032340.
8
USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes.USP25 通过稳定心肌细胞中的 SERCA2a 来改善病理性心肌肥厚。
Circ Res. 2023 Feb 17;132(4):465-480. doi: 10.1161/CIRCRESAHA.122.321849. Epub 2023 Feb 1.
9
Role of sevoflurane in myocardial ischemia-reperfusion injury via the ubiquitin-specific protease 22/lysine-specific demethylase 3A axis.七氟醚通过泛素特异性蛋白酶 22/赖氨酸特异性去甲基酶 3A 轴在心肌缺血再灌注损伤中的作用。
Bioengineered. 2022 May;13(5):13366-13383. doi: 10.1080/21655979.2022.2062535.
10
CYLD deubiquitinates plakoglobin to promote Cx43 membrane targeting and gap junction assembly in the heart.CYLD 通过去泛素化作用使斑联蛋白去泛素化,从而促进心脏中缝隙连接蛋白 43 的膜靶向和缝隙连接组装。
Cell Rep. 2022 Dec 27;41(13):111864. doi: 10.1016/j.celrep.2022.111864.